Publications by authors named "Sarah E Fagan"
Article Synopsis
- ABO blood group and inherited gene mutations can affect pancreatic cancer risk in first-degree relatives (FDRs) of pancreatic cancer patients, but their combined impact is still unclear.
- Research of 23,739 FDRs showed a higher cancer risk linked to mutation-positive probands, with a significant increase compared to those who were mutation-negative (3.80 vs. 1.79 risk ratio).
- Overall, while ABO blood group alone did not significantly alter cancer risk levels, FDRs of mutation-positive probands with non-O blood types exhibited the highest risk.
The purpose of this study is to explore existing research on determinants of cervical cancer screening among immigrants and refugees in the U.S. A scoping review was conducted on 77 studies targeting immigrant and/or refugee women in the U.
View Article and Find Full Text PDFBackground: Increased risk of malignancies other than pancreatic cancer (PC) has been reported among first-degree relatives (FDRs) of PC patients; however, the roles of susceptibility gene mutations are unclear. We assessed risk for 15 cancers among FDRs of unselected PC probands.
Methods: Data on 17 162 FDRs, with more than 336 000 person-years at risk, identified through 2305 sequential PC probands enrolled at Mayo Clinic (2000-2016) were analyzed.